HYDROXYCARBAMIDE CAP 500 MG 10 UNITS HYDREA BRISTOL-MYERS SQUI (excluded of 20 USD Postage fee/order)

HYDROXYCARBAMIDE is primarily used in the treatment of myeloproliferative diseases such as essential thrombocythemia and polycythemia.
12.80 USD
Order Quantity Price Per Item
10 10.24 USD
Total Price:

INDICATION AND DOSAGE OF HYDROXYCARBAMIDE

 

What It Is

Hydroxycarbamide, commonly known as hydroxyurea, is a medication primarily used in the treatment of certain types of cancer and blood disorders. It is classified as an antineoplastic and antimetabolite agent. Hydroxycarbamide works by interfering with DNA synthesis, which makes it effective in treating conditions characterized by rapid cell proliferation.

Dosage Forms and Strengths

Hydroxycarbamide is available in various dosage forms and strengths. The most common form is oral tablets, which are typically available in strengths of 100 mg, 200 mg, and 500 mg. The dosage strength and form can vary based on the manufacturer and the specific medical condition being treated.

Brand and Generic Names

Hydroxycarbamide is marketed under several brand names, including:

  • Hydrea (brand name)
  • Droxia (brand name)

The generic name for Hydroxycarbamide is simply hydroxyurea. The generic form is widely available and is often more cost-effective than brand-name versions.

Indications for Use

Hydroxycarbamide is prescribed for a variety of medical conditions, including:

  • Chronic Myeloid Leukemia (CML): A type of cancer that affects the blood and bone marrow.
  • Sickle Cell Disease: A genetic disorder characterized by abnormally shaped red blood cells that can lead to painful episodes and other complications.
  • Polycythemia Vera: A type of blood cancer that results in an increased number of red blood cells.
  • Essential Thrombocythemia: A blood disorder involving an overproduction of platelets.

Mechanism of Action

The primary mechanism of action of hydroxycarbamide involves the inhibition of ribonucleotide reductase, an enzyme crucial for DNA synthesis. By interfering with this enzyme, hydroxycarbamide effectively reduces the production of deoxyribonucleotides, the building blocks required for DNA replication and repair. This action leads to a reduction in the proliferation of cancerous cells and abnormal blood cells, making it a valuable therapeutic agent in oncology and hematology.

Administration and Dosage

Hydroxycarbamide is administered orally, and the dosage regimen depends on the specific condition being treated. Typical dosing schedules include:

  • Chronic Myeloid Leukemia: The dose is often adjusted based on the patient's response and tolerance but commonly ranges from 500 mg to 2000 mg daily.
  • Sickle Cell Disease: The standard dose is generally between 15 mg/kg to 35 mg/kg daily, adjusted according to the patient's response and tolerance.
  • Polycythemia Vera and Essential Thrombocythemia: Doses can vary widely, with adjustments made based on the patient's blood counts and clinical response.

The dosage must be tailored to the individual, taking into account factors such as body weight, overall health, and the presence of any other medical conditions.

Effects and Precautions

Hydroxycarbamide can be effective but also carries a risk of side effects, including:

  • Common Side Effects: Nausea, vomiting, diarrhea, loss of appetite, and fatigue.
  • Hematological Effects: Myelosuppression, which can lead to anemia, leukopenia, and thrombocytopenia. Regular blood monitoring is essential to manage these effects.
  • Dermatological Effects: Skin rashes and ulcerations may occur.
  • Long-Term Risks: Prolonged use can increase the risk of secondary malignancies.

Patients on hydroxycarbamide should be monitored regularly for blood counts and any signs of adverse effects. It is crucial to follow the prescribing physician's guidelines and report any unusual symptoms promptly.

Conclusion

Hydroxycarbamide, or hydroxyurea, is a versatile and effective medication used in the management of various cancers and blood disorders. Its mechanism of action involves inhibiting DNA synthesis, which makes it beneficial for treating conditions characterized by abnormal cell proliferation. While it offers significant therapeutic benefits, careful management and monitoring are required to mitigate potential side effects and ensure optimal treatment outcomes. As with any medication, individual patient needs and responses vary, underscoring the importance of personalized medical care.

There are no reviews for this product.

Write Review

*
*
Note: Do not use HTML in the text.
*
captcha
*

GTM

Jinimed © 2026Powered By  AbanteCart